FDA Explores Employing Blockchain To Track Supplies Of Drug

The US Food and Drug Administration (FDA) needs to be certain that sketchy drugs do not find their path to pharmacies and hospitals, and it is considering a tech solution to keep medicine secure. The organization has rolled out a pilot program that will allow the supply chain of drug explore paths to track prescription medication. While the FDA is not certain about what tech firms would employ, it claimed that blockchain was one option. The same decentralized trust system that can track the origins of your lettuce can also identify that your pills arrived from a lawful source.

Firms have till March 11, 2019, to apply to take part in the program. You will have to wait a while to see the end results in widespread employment. The tracking system is not projected to take effect till 2023, 10 Years after the law obligating the tech (the Drug Supply Chain Security Act) went live.

On a related note, the Australian Department of Health earlier claimed that it is brainstorming on a project that employs blockchain to record who is authorizing its medical information. Joining hands with Vault Systems (the secure cloud provider) to host the information and Agile Digital (the local startup) for its distributed ledger tech, the department is discovering blockchain as a medium to establish who is authorizing medical information, why they are authorizing it, and to safely record research questions.

Talking to the media about the initiative, David Elliot (executive director of Agile Digital) claimed that the department was looking for a platform that supports health data research, while sustaining privacy on citizen information. “They mutually wish to make that information obtainable for health scientists, since in the enormous pile of information, there might be cancer cures, or at least any clues of such,” Elliot claimed.

Related Posts

Leave a Reply

Your email address will not be published.